Abstract:Irene Gonzalez, 1 Rocio Polvillo, 1, 2 Maximiliano Ruiz-Galdon, 1 Armando Reyes-Engel, 1 Jose Luis Royo 1 1 Department of Surgery, Biochemistry and Immunology School of Medicine, University of Malaga, Malaga, Spain; 2 Centro Andaluz de Biología del Desarrollo, Seville, 41013, Spain Correspondence: Armando Reyes-Engel; Jose Luis Royo Tel +34 952131531 ; +34 952136655 Email ; Purpose: Tryptophan is the only precursor of serotonin, the hormone which helps regulate key human functions such as appetite, memory, mood, and sexual behavior. Connections have been identified between serotonin system dysfunction and the molecular etiology and treatment of mood disorders in a wide range of studies. Proposals have been put forward to co-administer tryptophan supplementation together with serotonin reuptake inhibitors in major depression patients, and also to exploit the sub-therapeutic depressive status in healthy populations. The reported responses, however, have been very dissimilar and this uneven effect may largely be explained by interindividual genetic differences. Materials and Methods: We studied mood change in 138 healthy subjects using both Goldberg's General Health Questionnaire and the Profile of Mood States Questionnaire to determine the effects of a daily supplementation of 1g of tryptophan or placebo. Buccal DNA samples were provided and TPH1 (rs1800532), MAOA (rs3788862 and rs979605), MAOB (rs3027452), and COMT (rs6269 and rs4680) variants were genotyped. Results: MAOB rs3027452 was equally associated with tryptophan supplementation efficacy in the depression subscales of both questionnaires (ΔT-Score.D; ΔT-Score.TMD and ΔPOMS.D p-values < 0.01). Conclusion: Here we provide evidence that tryptophan supplementation has an uneven effect on mood improvement in the general population. Keywords: tryptophan, serotonin, 5-HT, mood, pharmacogenetics, monoamine oxidase Tryptophan (Trp) is an essential amino acid that has to be ingested through protein-rich foods. Plasma Trp levels are the result of both intake and plasma clearance rates. 1 , 2 Trp is the only precursor of serotonin (5-hydroxytryptamine or 5-HT), which is produced both peripherally and centrally. In the central nervous system, 5-HT regulates key functions such as appetite, memory, mood, and sexual activity. 3 The implication of 5-HT in the pathophysiology and treatment of mood disorders has been studied extensively. Mood disturbance is one of the main symptoms of depression, an affective disorder which is the leading cause of disability worldwide. 4 The main therapeutic agents used to treat depression are antidepressants like 5-HT reuptake inhibitors, which can be prescribed alone or in combination with serotonin/noradrenaline reuptake inhibitors. 5 Selective serotonin reuptake inhibitors (SSRIs) act by inhibiting the reuptake of 5-HT into presynaptic cells and thus increasing its extracellular concentration. This increases the amount of 5-HT in the synaptic cleft, binding it to the postsynaptic receptors. SSRIs display different degrees of selectivity for other monoamines such as dopamine and norepinephrine transporters. 6 The benefits of increased monoamine levels were discovered in the 1950s, when monoamine oxidase (MAO) inhibitors and tricyclic antidepressants were found to be efficient in treating major depression patients. This led to the hypothesis that depression was caused by a deficiency in monoamine neurotransmitters. 7 However, antidepressants are only partially effective in the treatment of moderate to severe depression in adults, suggesting that potential pharmacogenetic effects may condition treatment efficiency. 7–11 The benefits of Trp for mood were first reported in the late fifties by Lauer et al 1958 12 . Some early studies conducted with depressed patients found that a daily supplementation of 3.5–18 g of Trp enhanced the therapeutic benefits of MAO inhibitors and tricyclic antidepressants. 13–15 However, although effective in mild to moderately depressed patients, Trp supplementation has been shown to have little or no effect in severely depressed patients. 16 The effects of Trp supplementation on mood in healthy volunteers have also been very varied. Markus et al investigated the effects of different sources -Abstract Truncated-

Mood, Prolactin and Cortisol Responses Following Intravenous L-tryptophan Challenge: Evidence for Serotonergic Vulnerability in First-Degree Relatives of Bipolar Patients.

Impaired blood-brain barrier in the microbiota-gut-brain axis: Potential role of bipolar susceptibility gene <i>TRANK1</i>

Lower High-Density Lipoprotein Cholesterol and Increased Omega-6 Polyunsaturated Fatty Acids in First-Degree Relatives of Bipolar Patients

The Effects of Tryptophan Depletion on Cognitive and Affective Processing in Healthy Volunteers

Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion

Sex‐linked Differences in Cortisol, ACTH and Prolactin Responses to 5‐hydroxy‐tryptophan in Healthy Controls and Minor and Major Depressed Patients

The Cortisol Responses to 5-Hydroxytryptophan, Orally, in Depressive Inpatients.

Serum neuroactive metabolites of the tryptophan pathway in patients with acute phase of affective disorders

MAOB rs3027452 Modifies Mood Improvement After Tryptophan Supplementation

Tryptophan supplementation and serotonin function: genetic variations in behavioural effects

Relationships Between Lower Plasma L-tryptophan Levels and Immune-Inflammatory Variables in Depression

A central serotonin regulating gene polymorphism (TPH2) determines vulnerability to acute tryptophan depletion-induced anxiety and ventromedial prefrontal threat reactivity in healthy young men

Influences on cortisol and noradrenergic turnover of healthy controls and depressed patients during L-tryptophan loading

Serotonin-immune Interactions in Major Depression: Lower Serum Tryptophan As a Marker of an Immune-Inflammatory Response

Significantly Increased Urinary Free Cortisol Excretion in Melancholic Depressed Females During L‐tryptophan Loading

The serotonin transporter gene-linked polymorphic region (5-HTTLPR) and the sleep-promoting effects of tryptophan: A randomized placebo-controlled crossover study

State and Trait Serotonin Variations Interact to Shape the Intrinsic Connectivity and Gradient Architecture of the Brain: a Combined TPH2 Genetics and Tryptophan Depletion Study

Tryptophan depletion in normal volunteers produces selective impairments in learning and memory.

Lower Serum L-Tryptophan Availability in Depression As a Marker of a More Generalized Disorder in Protein Metabolism

Individual Differences in Threat Sensitivity Predict Serotonergic Modulation of Amygdala Response to Fearful Faces

Selective association of cytokine levels and kynurenine/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression